Cargando…
Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
BACKGROUND: Because wide variations in mental health care utilization exist throughout the world, determining long-term effectiveness of psychotropic medications in a real-world setting would be beneficial to physicians and patients. The purpose of this analysis was to describe the effectiveness of...
Autores principales: | Lambert, Tim, Olivares, José M, Peuskens, Joseph, DeSouza, Cherilyn, Kozma, Chris M, Otten, Patrick, Crivera, Concetta, Jacobs, An, Macfadden, Wayne, Mao, Lian, Rodriguez, Stephen C, Dirani, Riad, Akhras, Kasem S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090384/ https://www.ncbi.nlm.nih.gov/pubmed/21463526 http://dx.doi.org/10.1186/1744-859X-10-10 |
Ejemplares similares
-
Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)
por: Crivera, Concetta, et al.
Publicado: (2011) -
Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
por: Macfadden, Wayne, et al.
Publicado: (2011) -
Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension
por: Kozma, Chris M, et al.
Publicado: (2010) -
Report of three cases that received maintenance treatment with risperidone as a mood stabilizer
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2004) -
A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2004)